World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
56133
World Ranking
12417
National Ranking
470

Luca Richeldi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Luca Richeldi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 471 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Luca Richeldi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Luca Richeldi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Luca Richeldi is affiliated with the Catholic University of the Sacred Heart in Italy. Their research primarily focuses on the field of Medicine, with a significant emphasis on Pulmonary and Respiratory Medicine. The scientist has contributed extensively to studies on interstitial lung diseases and idiopathic pulmonary fibrosis, alongside research in sarcoidosis and beryllium toxicity.

Their work also covers topics such as medical imaging and pathology studies, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, respiratory and cough-related research, and the long-term effects of COVID-19.

Frequent coauthors in their research include Giacomo Sgalla, Toby M. Maher, Vincent Cottin, Francesco Varone, and Susanne Stowasser.

Richeldi's publications have appeared in several prominent journals, with the most common venues being the American Journal of Respiratory and Critical Care Medicine, Pneumologie, CHEST Journal, The Lancet Respiratory Medicine, and the New England Journal of Medicine.

Some recent papers authored or coauthored by Richeldi include:

  • The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic, 2020, CHEST Journal
  • The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society, 2020, Radiology
  • Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial, 2020, The Lancet Respiratory Medicine
  • Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society, 2020, The Lancet Respiratory Medicine
  • Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities, 2020, The Lancet Respiratory Medicine

Best Publications

  • An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management

    Ganesh Raghu;Harold R. Collard;Jim J. Egan;Fernando J. Martinez

  • Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

    Luca Richeldi;Roland M. du Bois;Ganesh Raghu;Arata Azuma

  • An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

    William D. Travis;Ulrich Costabel;David M. Hansell;Talmadge E. King

  • Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

    Ganesh Raghu;Martine Remy-Jardin;Jeffrey L. Myers;Luca Richeldi

  • An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline

    Ganesh Raghu;Bram Rochwerg;Yuan Zhang;Carlos A. Cuello Garcia

  • The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society

    Geoffrey D. Rubin;Christopher J. Ryerson;Linda B. Haramati;Nicola Sverzellati

  • Idiopathic pulmonary fibrosis

    Luca Richeldi;Luca Richeldi;Harold R Collard;Mark G Jones

  • Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

    Luca Richeldi;Ulrich Costabel;Moises Selman;Dong Soon Kim

  • Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

    Collard Hr;Ryerson Cj;Corte Tj;Jenkins G

  • Idiopathic pulmonary fibrosis

    Fernando J Martinez;Harold R Collard;Annie Pardo;Ganesh Raghu

  • Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.

    David A Lynch;Nicola Sverzellati;William D Travis;Kevin K Brown

  • An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

    Aryeh Fischer;Katerina M. Antoniou;Kevin K. Brown;Jacques Cadranel

  • Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children

    David M. Lewinsohn;Michael K. Leonard;Philip A. LoBue;David L. Cohn

  • Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study

    Giovanni Ferrara;Monica Losi;Roberto D'Amico;Pietro Roversi

  • HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.

    Luca Richeldi;Rosa Sorrentino;Cesare Saltini

  • Idiopathic pulmonary fibrosis: pathogenesis and management.

    Giacomo Sgalla;Bruno Iovene;Mariarosaria Calvello;Margherita Ori

  • Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials

    Luca Richeldi;Vincent Cottin;Roland M. du Bois;Moisés Selman

  • Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

    Athol U. Wells;Kevin R. Flaherty;Kevin K. Brown;Yoshikazu Inoue

  • An update on the diagnosis of tuberculosis infection.

    Luca Richeldi

  • Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society

    Hiroto Hatabu;Gary M Hunninghake;Luca Richeldi;Kevin K Brown

Frequent Co-Authors

Ganesh Raghu
Ganesh Raghu University of Washington
Vincent Cottin
Vincent Cottin Claude Bernard University Lyon 1
Harold R. Collard
Harold R. Collard University of California, San Francisco
Leonardo M. Fabbri
Leonardo M. Fabbri University of Ferrara
Kevin R. Flaherty
Kevin R. Flaherty University of Michigan–Ann Arbor
Athol U. Wells
Athol U. Wells Imperial College London
Mark Jones
Mark Jones Bond University
Martin Kolb
Martin Kolb McMaster University
Kevin K. Brown
Kevin K. Brown National Jewish Health
Ulrich Costabel
Ulrich Costabel University of Duisburg-Essen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t just mean attending traditional medical school. There are a variety of online pathways that can accelerate your entry into healthcare or help you advance your existing nursing credentials.

For registered nurses looking to level up their skills without a heavy clinical commitment, rn bsn online programs no clinicals offer a flexible alternative. These programs help RNs earn a bachelor’s degree primarily online, making it easier to balance work and study.

Nurses aiming for the highest clinical and leadership roles can consider dnp online programs. Some 1 year dnp program online options provide accelerated paths to a Doctor of Nursing Practice, getting you into advanced positions faster than traditional timelines.

If you’re new to nursing, accelerated lpn programs can quickly set you on a healthcare career track. These condensed, online-friendly courses are designed for those eager to start working or continue their education towards higher degrees.

Best Scientists Citing Luca Richeldi

Trending Scientists

Recently Published Articles